Zusammenfassung
Lokale Antibiotika und Antiseptika sind bewährte Therapeutika bei Entzündungen im Mund-, Kiefer- und Gesichtsbereich. Während die Antiseptika sowohl in der Prophylaxe zur Prävention inflammatorischer Ereignisse als auch in der Therapie zur Anwendung kommen, werden die lokalen Antibiotika nur in der antiinfektiösen Therapie eingesetzt. Aufgrund ihres engen Wirkungsspektrums werden die lokalen Antibiotika häufig mit Antiseptika oder anderen Wirkstoffen wie Lokalanästhetika oder Glukokortikoiden kombiniert, um die therapeutische Wirkung zu verstärken. Durch den lokalisierten Einsatz von Antibiotika und Antiseptika lassen sich Entzündungen im Mund-Rachen-Raum vermeiden bzw. therapieren.
Abstract
Local antibiotics and antiseptic gels or solutions are proven therapeutics in the treatment of inflammation and diseases in oral and maxillofacial medicine. Whereas antiseptics are used as prophylaxis for preventing and also in the treatment of inflammatory events, local antibiotics are only used for treatment of inflammatory infections. Due to a narrow spectrum of effectiveness local antibiotics are often combined with antiseptics or with other active agents, such as anti-infective gels or solutions, local anesthetics and glucocorticoids to strengthen the therapeutic effectiveness. By the localized administration of antibiotics and antiseptics, inflammation in the oral and maxillofacial region can be prevented or treated.
Literatur
Al-Nawas B (2013) Antiinfektive Therapie der Osteomyelitis. MKG Chir 6:88–91
Behrens E, Kolenda I, Terheyden H, Wiltfang J (2004) Langzeitergebnisse mit dem ITI System. Implantologie 12 (2):133–147
Beikler T, Karch H, Flemming TF (2003) Adjuvante Antibiotika in der Parodontitistherapie. Dtsch Zahnärztl Z 58:263–265
Bidault P, Chandad F, Grenier D (2007) Systemic antibiotic therapy in the treatment of periodontitis. J Can Dent Assoc 73:515–520
Brodt HR (2012) Antibiotika-Therapie. Schattauer, Stuttgart, S 236–247
Bücher A, Meyer U, Kruse-Lösler B et al (2004) Sustained release of doxycycline for the treatment of periimplantitis: randomised controlled trial. Br J Oral Maxillofac Surg 42:439–444
Charles CH, Mostler KM, Bartels LL, Mankodi SM (2004) Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. J Clin Peridontol 31(10):878–884
Chen Y, Wong RW, Seneviratne CJ et al (2011) Comparison of the antimicrobial activity of listerine and corsodyl on orthodontic brackets in vitro. Am J Orthod Dentofacial Orthop 140(4):537–542
Demirer S, Ozdemir H, Sencan M, Marakoglu I (2007) Gingival hyperplasia as an early diagnostic oral manifestation in acute monocytic leukemia: a case report. Eur J Dent 1(2):111–114
Demmer RT, Holtfreter B, Desvarieux M et al (2012) The influence of type 1 and type 2 diabetes on periodontal disease progression: prospective results from the Study of Health in Pomerania (SHIP). Diabetes Care 35(10):2036–2042
Eickholz P, Dannewitz B, Kim TS (2012) Systemische Antibiotika in der parodontalen Therapie. Parodontologie 23:315–322
Ennebi O, Lakhdar L, Bouziane A et al (2013) Chlorhexidine alcohol base mouthrinse versus chlorhexidine formaldehyde base mouthrinse efficacy on plaque control: double blind, randomized clinical trials. Med Oral Patol Oral Cir Bucal 18(1):e135–e139
Goutham BS, Manchanda K, Sarkar AD et al (2013) Efficacy of two commercially available oral rinses – chlorohexidine and listrine on plaque and gingivitis – a comparative study. J Int Oral Health 5(4):56–61
Gunsolley JC (2010) Clinical efficacy of antimicrobial mouthrinses. J Dent 38(1 Suppl):S6–S10
Harke HP, Streek M (1989) Octenidin – ein neuer antimikrobieller Wirkstoff. Hyg Med 14:372–374
Harks I, Jockel-Schneider Y, Ehmke B (2012) Adjuvante systemische Antibiotikagabe in der Parodontitistherapie. Quintessenz 63(9):1149–1153
Herdegen T (2013) Lehrbuch Pharmakologie. Thieme, Stuttgart, S 565–568
Hierholzer G, Reimer K, Weissenbacher ER (HG) (1996) Topische Infektionstherapie und Prophylaxe. Aktueller Stellenwert von PVP-lod. Thieme, Stuttgart, S 19–23
Khoury F, Buchmann R (2001) Surgical therapy of peri-implant disease: a 3-year follow-up study of cases with 3 different techniques of bone regeneration. J Periodontol 72:1498–1508
Kluin OS, Mel HC van der, Busscher HJ, Neut D (2013) Biodegradable vs non-biodegradable antibiotic delivery devices in the treatment of osteomyelitis. Expert Opin Drug Deliv 10(3):341–351
Lambrecht JT (2004) Antibiotische Prophylaxe und Therapie in der zahnärztlichen Chirurgie. Schweiz Monatsschr Zahnmed 114(6):601–607
Lorenz K, Bruhn G, Heumann C et al (2006) Effect of two new chlorhexidine mouthrinses on the development of dental plaque, gingivitis, and discoloration. A randomized, double-blind, placebo-controlled, three week experimental gingivitis study. J Clin Periodontol 33:561–567
Mäkinen T, Veiranto M, Lankinen P et al (2005) In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect filler. J Antimicrob Chemother 56:1063–1068
Matesanz-Perez P, Garcia-Gargallo M, Figuero E et al (2013) A systematic review on the effects of local antimicrobials as adjuncts to subgingival debridement, compared with subgingival debridement alone, in the treatment of chronic periodontitis. J Clin Periodontol 40:227–241
Mombelli A, Lang NP (1992) Antimicrobial treatment of peri-implant infections. Clin Oral Implants Res 3:162–168
Moshrefi A (2002) Chlorhexidine. J West Soc Periodontol Periodontal Abstr 50(1):5–9
Neely AL (2012) Essential oil mouthwash (EOMW) may be equivalent to chlorhexidine (CHX) for long-term control of gingival inflammation but CHX appears to perform better than EOMW in plaque control. J Evid Based Dent Pract 12(3 Suppl):69–72
Neuschl M, Becker St, Behrens E, Wiltfang J (2011) Behandlungsoptionen in der Therapie periimplantärer Entzündungen. Implantologie 19(2):141–148
Nolkemper S, Reichling J, Sensch KH, Schnitzler P (2009) Mechanism of herpes simplex virus type 2 suppression by propolis extracts. Phytomedicine 17(2):132–138
Paolantonio M et al (2008) Internal decontamination of dental implants: an in vivo randomized microbiologic 6-month trial on the effects of a chlorhexidine gel. J Periodontol 79(8):1419–1425
Patel RM, Malaki Z (2008) The effect of a mouthrinse containing essential oils on dental plaque and gingivitis. Evid Based Dent 9(1):18–19
Persson GR, Salvi GE, Heitz-Mayfield LJ, Lang NP (2006) Antimicrobial therapy using a local drug delivery system (Arestin) in the treatment of peri-implantitis I: microbiological outcomes. Clin Oral Implants Res 17:63–76
Pigrau C, Almirante B, Rodriguez D et al (2008) Osteomyelitis of the yaw: resistance to clindamycin in patients with prior antibiotics exposure. Eur J Clin Microbiol Infect Dis 28:317–323
Pitten FA, Kramer A (1999) Antimicrobial efficacy of antiseptic mouthrinse solutions. Eur J Clin Pharmacol 55:95–100
Pitten FA, Rosin M, Kramer A (2001) Leitlinienentwurf: Indikationen und Wirkstoffauswahl zur prophylaktischen und therapeutischen Mundhöhlenantiseptik. Hyg Med 26 (10):419–424
Redleaf ME, Bauer CA (1994) Topical antiseptic mouthwash in oncological surgery of the oral cavity and oropharynx. J Laryngol Otol 108(11):973–979
Renvert S, Lessem J, Dahlen G et al (2008) Mechanical and repeated antimicrobial therapy using a local drug delivery system in the treatment of peri-implantitis- a randomized clinical trial. J Periodontol 79:836–844
Schenk G, Flemming T, Betz T et al (1997) Controlled local delivery of tetracycline HCI in the treatment of periimplant mucosal hyperplasia and mucositis. A controlled case series. Clin Oral Implants Res 8:427–433
Sedghizadeh PP, Kumar SK, Gorur A et al (2009) Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy. J Am Dent Assoc 140:1259–1265
Subramani K, Wismeijer D (2012) Decontamination of titanium implant surface and re-osseointegration to treat peri-implantitis: a literature review. Int J Oral Maxillifac Implants 27(5):1043–1054
Van Strydonck DA, Slot DE, Van der Velden U, Van der Weijden F (2012) Effect of a chlorhexidine mouthrinse on plaque, gingival inflammation and staining in gingivitis patients: a systematic review. J Clin Periodontol 39(11):1042–1055
Zitzmann NU, Walter C, Berglund T (2006) Ätiologie, Diagnostik und Therapie der Periimplantitis – eine Übersicht. Dtsch Zahnärztl Z 61(12):642–649
Deutsche Gesellschaft für Zahn-, Mund- und Kieferheilkunde. Wissenschaftliche Stellungnahme: Adjuvante Antibiotika in der Parodontitistherapie. http://www.dgzmk.de/uploads/tx_szdgzmkdocuments/Adjuvante_Antibiotika_in_der_Parodontitistherapie.pdf. Zugegriffen: 31. Mai 2014
Deutsche Gesellschaft für Zahn-, Mund- und Kieferheilkunde. Wissenschaftliche Stellungnahme: Chronisch rezidivierende Aphthen. http://www.dgzmk.de/uploads/tx_szdgzmkdocuments/20040201_Chronisch_rezidivierende_Aphthen.pdf?PHPSESSID=06ebc0529f30bdc60e3f1b115fc6add3. Zugegriffen: 03. Juni 2014
Kramer A et al (2004) Konsensusempfehlung Antiseptik. http://www.werner-sellmer.de/Downloads/Leitlinien/Konsensusempfehlung%20Wundantiseptik%202004%20Deutsch.pdf. Zugegriffen: 03. Juni 2014
Einhaltung ethischer Richtlinien
Interessenkonflikt. E. Behrens und T. Herdegen geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Behrens, E., Herdegen, T. Lokale Antibiotika und Antiseptika. MKG-Chirurg 7, 268–273 (2014). https://doi.org/10.1007/s12285-013-0416-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12285-013-0416-1